https://www.selleckchem.com/products/tpx-0005.html
In summary, the present study demonstrated that IFIT2 was efficacious in inhibiting CML and is a potential therapeutic target.Glioma is the most common primary malignancy of the central nervous system and is associated with high mortality rates. Despite the available treatment options including surgery, radiotherapy and chemotherapy, the median patient survival rate is low. Therefore, the development of novel anticancer agents for the treatment of glioma is urgently required. Tanshinone I (TS I) is a tanshinone compound that is isolate
Like
Comment
Share
